Blucora Inc (INSP) Stock Price While Sentiment Increases to 1.25

“Big money” Positions

“Big money sentiment for Blucora Inc (INSP) in Q2 2018 increased to 1.25, according to SEC filings. That’s up 0.20, from 2018Q1’s 1.05. 94 institutional investors started new or increased stock positions, while 75 sold and trimmed stock positions in Blucora Inc so the sentiment is positive. These funds own 43.70 million shares, that’s up from 43.55 million shares in 2018Q1. Funds holding Blucora Inc in top 10 increased from 2 to 3 for an increase of 1. In total 17 funds closed positions, 58 reduced and 59 increased. Also 35 funds bought new Blucora Inc stakes.

Most Blucora Inc Shareholders

As of Q2 2018 Harvest Capital Strategies Llc has 3.81% invested in Blucora Inc. As of Q2 2018, 432,956 shares of Blucora Inc are owned by Hillcrest Asset Management Llc. Furthermore, Oberweis Asset Management Inc reported 209,614 shares in Blucora Inc equivalent to 1.95% of its fund portfolio. The Wisconsin-based fund Timpani Capital Management Llc have invested about 0.83% of the investment manager’s stock portfolio in Blucora Inc. The California-based fund Park West Asset Management Llc holds 550,000 shares or 0.76% of their fund portfolio.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea .The company has $990.60 million market cap. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.Currently it has negative earnings.

INSP is reaching $46.39 during the last trading session, after decreased 11.38%.Inspire Medical Systems, Inc. has 661,398 shares volume, 327.22% up from normal. INSP is and has moved 0.00% since November 10, 2017. INSP underperformed by 15.62% the S&P500.

Fuller And Thaler Asset Mgmt Inc owns 0.33% invested in Inspire Medical Systems, Inc. (NYSE:INSP) for 814,391 shs. Royal Bank & Trust Of Canada holds 0% or 16,366 shs. Employees Retirement Systems Of Ohio has 110,644 shs. California State Teachers Retirement Sys stated it has 0.01% of its capital in Inspire Medical Systems, Inc. (NYSE:INSP). Moreover, Advisory Network Lc has 0.01% invested in Inspire Medical Systems, Inc. (NYSE:INSP). Mutual Of America Cap Mgmt Limited Liability has invested 0% of its capital in Inspire Medical Systems, Inc. (NYSE:INSP). 48,146 are owned by Teachers Retirement Systems Of The State Of Kentucky. Cap One Natl Association stated it has 0.04% in Inspire Medical Systems, Inc. (NYSE:INSP). Employees Retirement Association Of Colorado holds 13,342 shs. Mason Street Advsrs Llc reported 13,567 shs or 0.01% of all its holdings. Kessler Lc has invested 0.22% of its capital in Inspire Medical Systems, Inc. (NYSE:INSP). Jpmorgan Chase And reported 525,047 shs. Pub Sector Pension Investment Board invested in 0.01% or 30,250 shs. 40 are held by First Manhattan Com. The Georgia-based Voya Invest Management Ltd has invested 0% in Inspire Medical Systems, Inc. (NYSE:INSP).

Inspire Medical Systems, Inc. had 2 sales and 0 buys since May 11, 2018. This’s net activity of $3.11 million. On Thursday, August 23 Palmer John David also sold $135,108 worth of Inspire Medical Systems, Inc. (NYSE:INSP).

Inspire Medical Systems, Inc. (NYSE:INSP) Ratings Coverage

In total 6 analysts cover Inspire Medical Systems (INSP). “Buy” rating has 4, “Sell” are 0, while 2 are “Hold”. 67% are bullish. 6 are the (INSP)’s analyst reports since May 29, 2018 according to StockzIntelligence Inc. On Tuesday, May 29 the company was initiated by Bank of America.

For more Inspire Medical Systems, Inc. (NYSE:INSP) news released recently go to: Benzinga.com, Nasdaq.com, Seekingalpha.com, Globenewswire.com or Benzinga.com. The titles are as follows: “The Daily Biotech Pulse: EyePoint Licenses Eye Inflammation Drug, Insys Strategic Review Of Opioid Assets, Neos …” released on November 06, 2018, “Inspire Medical Systems, Inc. to Present at the Stifel 2018 Healthcare Conference” on October 25, 2018, “Three sell-siders bullish on Kodiak Sciences in premarket analyst action” with a publish date: October 29, 2018, “Inspire Medical Systems, Inc. to Report Third Quarter 2018 Financial Results November 6, 2018” and the last “The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs” with publication date: November 04, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.